These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 28012100)
1. The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis. La Milia V; Longhi S; Sironi E; Pontoriero G J Nephrol; 2018 Feb; 31(1):137-145. PubMed ID: 28012100 [TBL] [Abstract][Full Text] [Related]
2. Early Detection of Imminent Encapsulating Peritoneal Sclerosis: Free Water Transport, Selected Effluent Proteins, or Both? Barreto DL; Sampimon DE; Struijk DG; Krediet RT Perit Dial Int; 2019; 39(1):83-89. PubMed ID: 30478138 [TBL] [Abstract][Full Text] [Related]
3. Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis. Goodlad C; Tam FW; Ahmad S; Bhangal G; North BV; Brown EA Perit Dial Int; 2014; 34(6):594-604. PubMed ID: 24584593 [TBL] [Abstract][Full Text] [Related]
4. Encapsulating peritoneal sclerosis in an Italian center: thirty year experience. Vizzardi V; Sandrini M; Zecchini S; Ravera S; Manili L; Cancarini G J Nephrol; 2016 Apr; 29(2):259-267. PubMed ID: 26521254 [TBL] [Abstract][Full Text] [Related]
5. Peritoneal Equilibration Test Reference Values Using a 3.86% Glucose Solution During the First Year of Peritoneal Dialysis: Results of a Multicenter Study of a Large Patient Population. La Milia V; Cabiddu G; Virga G; Vizzardi V; Giuliani A; Finato V; Feriani M; Filippini A; Neri L; Lisi L; Perit Dial Int; 2017; 37(6):633-638. PubMed ID: 28698252 [TBL] [Abstract][Full Text] [Related]
6. Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis. Chang MS; Chen NC; Hsu CY; Huang CW; Lee PT; Chou KJ; Fang HC; Chen CL Ren Fail; 2020 Nov; 42(1):1-9. PubMed ID: 31826694 [No Abstract] [Full Text] [Related]
7. Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis. Morelle J; Sow A; Hautem N; Bouzin C; Crott R; Devuyst O; Goffin E J Am Soc Nephrol; 2015 Oct; 26(10):2521-33. PubMed ID: 25636412 [TBL] [Abstract][Full Text] [Related]
8. Absence of Post-Transplantation Encapsulating Peritoneal Sclerosis after Relatively Short Exposure to Peritoneal Dialysis: Prospective Analysis Using Repeated Abdominal CT Scanning. Abrahams AC; van Gelder MK; van der Veer JW; de Jong PA; van Leeuwen MS; Boer WH Perit Dial Int; 2017; 37(4):443-450. PubMed ID: 28676511 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital. Nakao M; Yamamoto I; Maruyama Y; Morishita M; Nakashima A; Matsuo N; Tanno Y; Ohkido I; Ikeda M; Yamamoto H; Yokoyama K; Yokoo T Nephrology (Carlton); 2017 Nov; 22(11):907-912. PubMed ID: 27556577 [TBL] [Abstract][Full Text] [Related]
10. Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study. Lambie MR; Chess J; Summers AM; Williams PF; Topley N; Davies SJ; Nephrol Dial Transplant; 2016 Mar; 31(3):480-6. PubMed ID: 26908833 [TBL] [Abstract][Full Text] [Related]
11. The mini-PET in pediatric peritoneal dialysis: a useful tool to predict volume overload? Cano F; Rojo A; Azocar M; Ibacache MJ; Delucchi A; Ugarte F; Irarrazabal C; Delgado I Pediatr Nephrol; 2013 Jul; 28(7):1121-6. PubMed ID: 23494552 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Yamamoto R; Otsuka Y; Nakayama M; Maruyama Y; Katoh N; Ikeda M; Yamamoto H; Yokoyama K; Kawaguchi Y; Matsushima M Clin Exp Nephrol; 2005 Jun; 9(2):148-52. PubMed ID: 15980950 [TBL] [Abstract][Full Text] [Related]
14. A Large Intraperitoneal Residual Volume Hampers Adequate Volumetric Assessment of Osmotic Conductance to Glucose. Clause AL; Keddar M; Crott R; Darius T; Fillee C; Goffin E; Morelle J Perit Dial Int; 2018; 38(5):356-362. PubMed ID: 29674410 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients. Nakamoto H; Hamada C; Shimaoka T; Sekiguchi Y; Io H; Kaneko K; Horikoshi S; Tomino Y J Artif Organs; 2014 Mar; 17(1):60-8. PubMed ID: 24337623 [TBL] [Abstract][Full Text] [Related]
16. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Nakayama M; Miyazaki M; Honda K; Kasai K; Tomo T; Nakamoto H; Kawanishi H Perit Dial Int; 2014; 34(7):766-74. PubMed ID: 24497585 [TBL] [Abstract][Full Text] [Related]
17. Predicting solute transfer rate in patients initiating peritoneal dialysis. Jaques DA; Davenport A J Nephrol; 2024 May; 37(4):973-982. PubMed ID: 38289462 [TBL] [Abstract][Full Text] [Related]
18. Recent Understanding of Peritoneal Pathology in Peritoneal Dialysis Patients in Japan. Hamada C; Tomino Y Blood Purif; 2021; 50(6):719-728. PubMed ID: 33567422 [TBL] [Abstract][Full Text] [Related]
19. Risk factors and clinical outcomes of encapsulating peritoneal sclerosis: A case-control study from China. Lu M; Ye H; Chen D; Yi C; Lin J; Mao H; Yang X; Yu X; Chen W Perit Dial Int; 2022 Sep; 42(5):505-512. PubMed ID: 34259109 [TBL] [Abstract][Full Text] [Related]
20. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients. Alatab S; Najafi I; Pourmand G; Hosseini M; Shekarchian S Ren Fail; 2017 Nov; 39(1):32-39. PubMed ID: 27774831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]